Key facts
- This page summarizes Christopher I. Wright's Form 4 filing for Alkermes plc. (ALKS).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 22 May 2026, 20:08.
Christopher I. Wright - 20 May 2026 Form 4 Insider Report for Alkermes plc. (ALKS)
- Reporting relationship
- Director
- Issuer ticker
- ALKS
- Reported as of
- 20 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 May 2026, 20:08:26 UTC
- Prior SEC filing
- 17 Apr 2026
- Next SEC filing
- 12 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shantale Greenson, attorney-in-fact for Christopher I. Wright
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher I. Wright filed Form 4 for Alkermes plc. (ALKS) on 22 May 2026.
Change
- Previous filing in this sequence was filed on 17 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001838503
Primary reporting owner
Wright Christopher I
- Relationship
- Director
- Address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN, IRELAND
- Signature
- /s/ Shantale Greenson, attorney-in-fact for Christopher I. Wright
- Signature date
- 22 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALKS
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +6,142
- Change %
- +27%
- Price
- Shares after
- 29,155
- Date
- 21 May 2026
- Ownership
- Direct
- Footnotes
- F1
ALKS
transaction
Ordinary Shares
Tax liability
- Transaction value
- Shares
- -1,475
- Change %
- -5.1%
- Price
- $36.95*
- Shares after
- 27,680
- Date
- 21 May 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALKS
transaction
Derivative
Non Qualified Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +11,538
- Change %
- Price
- $0.000000*
- Shares after
- 11,538
- Date
- 20 May 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 11,538
- Exercise price
- $36.98
- Footnotes
- F2
ALKS
transaction
Derivative
Restricted Stock Unit Award
Award
- Transaction value
- Shares
- +5,409
- Change %
- Price
- $0.000000*
- Shares after
- 5,409
- Date
- 20 May 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 5,409
- Exercise price
- Footnotes
- F1, F2
ALKS
transaction
Derivative
Restricted Stock Unit Award
Options Exercise
- Transaction value
- Shares
- -6,142
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 May 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 6,142
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one ordinary share.
Footnote F2
Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant.
Footnote F3
This award is fully vested in accordance with its terms.